{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T14:40:23Z","timestamp":1776350423437,"version":"3.51.2"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T00:00:00Z","timestamp":1776211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Thymoma can trigger a spectrum of paraneoplastic neurological disorders, including autoimmune encephalitis (AE) and myasthenia gravis (MG). However, the sequential development of anti-\u03b1-amino-3-hydroxy-5-methyl-4-isoxazole-propionic acid receptor (AMPAR) autoimmune encephalitis followed by MG in the same patient is rarely reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To describe the clinical presentation, diagnostic work-up, treatment response, and outcome of a patient who developed thymoma-associated anti-AMPAR encephalitis and later presented with MG.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively reviewed the medical records, imaging findings, laboratory results, and treatment course of a 49-year-old man who was evaluated at our institution. Serum and cerebrospinal fluid (CSF) autoantibodies were screened using cell-based assays and indirect immunofluorescence.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The patient initially presented with subacute cognitive decline, confusion, and behavioral changes. CSF analysis revealed mild lymphocytic pleocytosis. Anti-AMPAR antibodies were positive in both serum and CSF, and contrast-enhanced chest computed tomography (CT) scan showed an anterior mediastinal mass consistent with thymoma. High-dose intravenous methylprednisolone followed by tapering oral prednisone, plasma exchange (PE), and intravenous immunoglobulin (IVIG) and rituximab led to marked neurological improvement. Two months after discharge, he developed left-sided ptosis, diplopia, and dyspnea. Repetitive nerve stimulation showed a decremental response, and serology was positive for acetylcholine receptor (AChR), titin, and ryanodine receptor (RyR) antibodies, establishing the diagnosis of MG. Symptoms improved substantially with prednisone and tacrolimus, and subsequent thymectomy combined with efgartigimod further achieved sustained clinical remission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This case illustrates that patients with anti-AMPAR encephalitis should be closely monitored for the subsequent emergence of MG, particularly when an underlying thymoma is present. Comprehensive antibody profiling is essential for early recognition and targeted immunotherapy. Long-term immunosuppression combined with tumor-directed treatment may be required to prevent relapses of both disorders and achieve optimal clinical outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1627951","type":"journal-article","created":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T09:09:29Z","timestamp":1776330569000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Thymoma-associated anti-AMPAR encephalitis with myasthenia gravis: a case report"],"prefix":"10.3389","volume":"17","author":[{"given":"Wenbin","family":"Teng","sequence":"first","affiliation":[{"name":"Department of Neurology, The Minzu Hospital of Guangxi Zhuang Autonomous Region","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuzan","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Minzu Hospital of Guangxi Zhuang Autonomous Region","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiqiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Minzu Hospital of Guangxi Zhuang Autonomous Region","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaodan","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Minzu Hospital of Guangxi Zhuang Autonomous Region","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruiting","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Minzu Hospital of Guangxi Zhuang Autonomous Region","place":["Nanning, China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2026,4,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awg133","article-title":"Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients","volume":"126","author":"Shams'ili","year":"2003","journal-title":"Brain"},{"key":"B2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70060-7","article-title":"Paraneoplastic syndromes of the CNS","volume":"7","author":"Dalmau","year":"2008","journal-title":"Lancet Neurol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2015.00171","article-title":"Limbic encephalitis: potential impact of adaptive autoimmune inflammation on neuronal circuits of the amygdala","volume":"6","author":"Melzer","year":"2015","journal-title":"Front Neurol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(11)70096-5","article-title":"Autoantibodies associated with diseases of the CNS: new developments and future challenges","volume":"10","author":"Vincent","year":"2011","journal-title":"Lancet Neurol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e318224afde","article-title":"Encephalitis and antibodies to synaptic and neuronal cell surface proteins","volume":"77","author":"Lancaster","year":"2011","journal-title":"Neurology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.cellbio.23.090506.123516","article-title":"The cell biology of synaptic plasticity: AMPA receptor trafficking","volume":"23","author":"Shepherd","year":"2007","journal-title":"Annu Rev Cell Dev Biol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.neuron.2018.07.048","article-title":"Human autoantibodies against the AMPA receptor subunit gluA2 induce receptor reorganization and memory dysfunction","volume":"100","author":"Haselmann","year":"2018","journal-title":"Neuron"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000003138","article-title":"AMPA receptors: dynamics and targets of disease","volume":"87","author":"Benarroch","year":"2016","journal-title":"Neurology"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2013.05.011","article-title":"Rapid progression and brain atrophy in anti-AMPA receptor encephalitis","volume":"261","author":"Wei","year":"2013","journal-title":"J Neuroimmunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001682","article-title":"Encephalitis and AMPA receptor antibodies: novel findings in a case series of 22 patients","volume":"84","author":"H\u00f6ftberger","year":"2015","journal-title":"Neurology"},{"key":"B12","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s12883-017-0823-4","article-title":"Hashimoto's encephalitis associated with AMPAR2 antibodies: a case report","volume":"17","author":"Zhu","year":"2017","journal-title":"BMC Neurol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/aww012","article-title":"Motor cortex and hippocampus are the two main cortical targets in LGI1-antibody encephalitis","volume":"139","author":"Navarro","year":"2016","journal-title":"Brain"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2018.01.011","article-title":"Thymoma-associated myasthenia gravis and LGI1-encephalitis, with nephrotic syndrome post-thymectomy","volume":"317","author":"Hor","year":"2018","journal-title":"J Neuroimmunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12883-019-1358-7","article-title":"Anti-\u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor GluR2 encephalitis in a myasthenia gravis patient with complete thymectomy: a case report","volume":"19","author":"Luo","year":"2019","journal-title":"BMC Neurol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nrn2055","article-title":"Regulatory mechanisms of AMPA receptors in synaptic plasticity","volume":"8","author":"Derkach","year":"2007","journal-title":"Nat Rev Neurosci"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21589","article-title":"AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location","volume":"65","author":"Lai","year":"2009","journal-title":"Ann Neurol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/ana.24293","article-title":"Cellular plasticity induced by anti-\u03b1-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor encephalitis antibodies","volume":"77","author":"Peng","year":"2015","journal-title":"Ann Neurol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/nou030","article-title":"Autoimmune encephalitis update","volume":"16","author":"Dalmau","year":"2014","journal-title":"Neuro Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000161","article-title":"Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures","volume":"2","author":"Flanagan","year":"2015","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/00001622-200009000-00007","article-title":"Thymoma","volume":"12","author":"M\u00fcller-Hermelink","year":"2000","journal-title":"Curr Opin Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2012.06.016","article-title":"Paraneoplastic extralimbic encephalitis associated with thymoma and myastenia gravis: three years follow up","volume":"115","author":"Aysal","year":"2013","journal-title":"Clin Neurol Neurosurg"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-016-8045-z","article-title":"Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society","volume":"263","author":"Melzer","year":"2016","journal-title":"J Neurol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2015.1444","article-title":"Clinical utility of acetylcholine receptor antibody testing in ocular myasthenia gravis","volume":"72","author":"Peeler","year":"2015","journal-title":"JAMA Neurol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.43.8.1581","article-title":"Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin","volume":"43","author":"Gautel","year":"1993","journal-title":"Neurology"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-017-8514-z","article-title":"Screening for lipoprotein receptor-related protein 4-, agrin-, and titin-antibodies and exploring the autoimmune spectrum in myasthenia gravis","volume":"264","author":"Cordts","year":"2017","journal-title":"J Neurol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.3581","article-title":"Thymoma-associated myasthenia gravis in a young adult with development of paraneoplastic limbic encephalitis and systemic lupus erythematosus post-thymectomy: a case report","volume":"10","author":"Liu","year":"2018","journal-title":"Cureus"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-023-07239-0","article-title":"Unique association of anti-GABAA receptor encephalitis and myasthenia gravis in a patient with type A thymoma","volume":"45","author":"Ouyang","year":"2024","journal-title":"Neurol Sci"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2015.02.011","article-title":"Anti-AMPA receptor encephalitis associated with thymomatous myasthenia gravis","volume":"281","author":"Li","year":"2015","journal-title":"J Neuroimmunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2015.04.003","article-title":"Autoimmune channelopathies in paraneoplastic neurological syndromes","volume":"1848","author":"Joubert","year":"2015","journal-title":"Biochim Biophys Acta"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1627951\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T13:41:21Z","timestamp":1776346881000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1627951\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,15]]},"references-count":30,"alternative-id":["10.3389\/fimmu.2026.1627951"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1627951","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,15]]},"article-number":"1627951"}}